These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2419299)

  • 1. Enoxacin concentration in human prostatic tissue after oral administration.
    Rannikko S; Malmborg AS
    J Antimicrob Chemother; 1986 Jan; 17(1):123. PubMed ID: 2419299
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enoxacin concentration in human prostatic tissue].
    Yasumoto R; Kobayakawa H; Asakawa M
    Hinyokika Kiyo; 1986 Oct; 32(10):1471-3. PubMed ID: 2436463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enoxacin concentration in human prostatic tissue after 3-day administration].
    Morita M; Kato M; Kuji S; Hasuda A
    Hinyokika Kiyo; 1988 Jul; 34(7):1293-6. PubMed ID: 2459943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study on enoxacin concentration in human prostatic tissue].
    Kitamura Y; Kataumi Z; Nakamura T; Takeda H
    Hinyokika Kiyo; 1990 Jan; 36(1):101-2. PubMed ID: 1689927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enoxacin concentration in seminal fluid, in prostate secretions and in prostatic adenoma tissue following oral administration or intravenous infusion].
    Naber KG; Sörgel F; Kees F; Schumacher H; Sigl G; Zürcher J; Berger S
    Infection; 1989; 17 Suppl 1():S30-6. PubMed ID: 2478481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of food on enoxacin absorption.
    Somogyi AA; Bochner F; Keal JA; Rolan PE; Smith M
    Antimicrob Agents Chemother; 1987 Apr; 31(4):638-9. PubMed ID: 3475034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion of tosufloxacin into prostatic tissue.
    Uchibayashi T; Hisazumi H; Kanayama J; Kumano K
    Chemotherapy; 1992; 38(3):150-4. PubMed ID: 1380905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo diffusion of enoxacin in healthy renal and adenomatous prostate tissue in man.
    Charton M; Timbal Y
    Eur Urol; 1990; 17(3):252-6. PubMed ID: 1693576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative pharmacokinetics of five quinolones.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of enoxacin and its oxometabolite after multiple oral dosing and penetration into prostatic tissue.
    Hamel B; Mottet N; Audran M; Costa P; Bressolle F
    J Antimicrob Chemother; 2000 Dec; 46(6):993-6. PubMed ID: 11102420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of pelvic tissue concentrations after oral administration of enoxacin.
    Bates SA; Elder MG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():79-85. PubMed ID: 3162905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of enoxacin in renal disease.
    Bury RW; Becker GJ; Kincaid-Smith PS; Moulds RF; Whitworth JA
    Clin Pharmacol Ther; 1987 Apr; 41(4):434-8. PubMed ID: 3470166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of enoxacin, ofloxacin, and norfloxacin concentration in human benign prostatic tissue].
    Yasumoto R; Asakawa M
    Hinyokika Kiyo; 1988 Aug; 34(8):1519-21. PubMed ID: 3195414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral treatment of systemic Pseudomonas aeruginosa infection with enoxacin.
    Hubrechts JM; Vanhoof R; Servais J; Toen R; Sacré J; van Gysel JP
    Lancet; 1984 Apr; 1(8381):860. PubMed ID: 6143180
    [No Abstract]   [Full Text] [Related]  

  • 15. Enoxacin distribution in human tissues after multiple oral administration.
    Malmborg AS; Rannikko S
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():57-60. PubMed ID: 3162902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enoxacin-warfarin interaction: pharmacokinetic and stereochemical aspects.
    Toon S; Hopkins KJ; Garstang FM; Aarons L; Sedman A; Rowland M
    Clin Pharmacol Ther; 1987 Jul; 42(1):33-41. PubMed ID: 3474093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxacin pharmacokinetics and efficacy in CF-1 mice.
    Chartrand SA; Scribner RK; Marks MI; Dice J
    J Antimicrob Chemother; 1987 Feb; 19(2):221-4. PubMed ID: 3553134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days.
    Dobbs BR; Gazeley LR; Stewart IA; Edwards IR
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():61-6. PubMed ID: 3162903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():67-77. PubMed ID: 3162904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Norfloxacin concentration in human prostatic tissue after 3 days administration].
    Morita M; Hasuda A
    Hinyokika Kiyo; 1989 Jul; 35(7):1261-5. PubMed ID: 2478009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.